These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Markaverich BM, Roberts RR, Alejandro MA, Clark JH. Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964 [Abstract] [Full Text] [Related]
7. Differential response to estriol and estradiol in the mouse uterus: correlation to an additional nuclear event. Korach K, Fox-Davies C, Baker V. Endocrinology; 1980 Jun; 106(6):1900-6. PubMed ID: 7371595 [No Abstract] [Full Text] [Related]
14. Different effects on oestrogen binding sites and anti-oestrogenic action of danazol and progesterone. Tamaya T, Wada K, Mori H, Imai A. Ann Clin Biochem; 1991 May; 28 ( Pt 3)():250-2. PubMed ID: 1872570 [Abstract] [Full Text] [Related]
16. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange. Markaverich BM, Williams M, Upchurch S, Clark JH. Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414 [Abstract] [Full Text] [Related]
19. Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. Clark JH, Williams M, Upchurch S, Eriksson H, Helton E, Markaverich BM. J Steroid Biochem; 1982 Feb; 16(2):323-8. PubMed ID: 7078167 [Abstract] [Full Text] [Related]